Advanced biologic therapies and cardiovascular events in patients with inflammatory bowel disease
Aims: Atherosclerotic cardiovascular disease (ASCVD) risk is increased in patients with Inflammatory Bowel Disease (IBD). The impact of advanced biologic therapies (ABT) on ASCVD risk in patients with IBD has not been reported. This study tests the hypothesis of a protective effect of immune modulat...
Saved in:
| Main Authors: | Lara Chaaban, Tarek Harb, Gary Gerstenblith, Thorsten M. Leucker, Joanna Melia |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | American Journal of Preventive Cardiology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666667725000662 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms
by: Joanna Balding, et al.
Published: (2004-01-01) -
Cardiovascular disease: extraintestinal manifestation of inflammatory bowel disease
by: Samridhi Lakhanpal, et al.
Published: (2025-01-01) -
Angiogenic Factors and Inflammatory Bowel Diseases
by: Zhiru Li, et al.
Published: (2025-05-01) -
Metabolic Disorders and Inflammatory Bowel Diseases
by: Hye Kyung Hyun, et al.
Published: (2025-05-01) -
The hidden burden: Inflammatory bowel disease and cardiovascular mortality in underreported populations
by: Jose Eric M. Lacsa
Published: (2025-09-01)